1-8 of 8
Mark J. Bishton
Close
Sort by
Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah
Journal: Blood
Blood (2021) 138 (Supplement 1): 181.
https://doi.org/10.1182/blood-2021-146737
Published: 2021
Journal Articles

The Pan Histone Deacetylase Inhibitor Panobinostat and the Iso-Selective Inhibitor Romidepsin Reduce Glycoprotein VI Expression and Inhibit Platelet Activation in Response to Collagen Related Peptide

Mark J Bishton, Miles Prince, MD, FRACP, FRCPA, Ricky W Johnstone, PhD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Benjamin T. Kile, PhD
Journal: Blood
Blood (2011) 118 (21): 1154.
https://doi.org/10.1182/blood.V118.21.1154.1154
Published: 2011
Journal Articles

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia

Mark J. Bishton, Simon J. Harrison, Benjamin P. Martin, Nicole McLaughlin, Chloé James, Emma C. Josefsson, Katya J. Henley, Benjamin T. Kile, H. Miles Prince, Ricky W. Johnstone
Journal: Blood
Blood (2011) 117 (13): 3658–3668.
https://doi.org/10.1182/blood-2010-11-318055
Published: 2011
Includes: Supplemental data
Journal Articles

Overcoming Histone Deacetylase Inhibitor Induced Thrombocytopenia Using a Thrombopoietin Mimetic.

Mark J Bishton, Miles Prince, Simon Harrison, Ben P Martin, Bsc, (Hons), Chloé James, MD, PhD, Benjamin T. Kile, PhD, R. W Johnstone
Journal: Blood
Blood (2009) 114 (22): 2416.
https://doi.org/10.1182/blood.V114.22.2416.2416
Published: 2009
Journal Articles

A Prospective Study of the Prognostic Impact of 18 [F]-FDG-PET and Molecular Response in Patients with Relapsed Indolent Non-Hodgkin Lymphoma (NHL) Following Iodine-131-Rituximab Radio-Immunotherapy (RIT).

Mark J. Bishton, MB, ChB, Rod Hicks, David Alan Westerman, Miles Prince, Max Wolf, John Francis Seymour
Journal: Blood
Blood (2007) 110 (11): 3421.
https://doi.org/10.1182/blood.V110.11.3421.3421
Published: 2007
Journal Articles

Repeat Treatment with Iodine-131-Rituximab Is Safe and Effective in Patients with Relapsed Indolent B-Cell Non-Hodgkin Lymphoma (NHL) Who Had Previously Responded to This Therapy.

Mark J. Bishton, MB, ChB, Michael F. Leahy, Rod J. Hicks, J. Harvey Turner, Ad McQuillan, John Francis Seymour
Journal: Blood
Blood (2007) 110 (11): 3413.
https://doi.org/10.1182/blood.V110.11.3413.3413
Published: 2007
Journal Articles

Treatment of Enteropathy Associated T Cell Lymphoma with Combination Chemotherapy Followed by Autologous Stem Cell Transplantation.

Mark J. Bishton, Andrew P. Haynes, Jenny L. Byrne, Nigel H. Russell
Journal: Blood
Blood (2006) 108 (11): 5424.
https://doi.org/10.1182/blood.V108.11.5424.5424
Published: 2006
Journal Articles

Ifosphamide, Etoposide and Epirubicin (IVE) Is an Effective Combined Salvage and Peripheral Blood Stem Cell Mobilisation Regimen for Transplant-Eligible Patients with Lymphoma.

Mark J. Bishton, Richard Lush, Nigel H. Russell, Bronwen E. Shaw, Andrew P. Haynes
Journal: Blood
Blood (2006) 108 (11): 2432.
https://doi.org/10.1182/blood.V108.11.2432.2432
Published: 2006